The Claim
In healthy postmenopausal women aged 45–70, a single dose of combined monoclonal antibodies blocking GDF8 (6 mg/kg) and activin A (10 mg/kg) increases thigh muscle volume by approximately 6% over 8 weeks and reduces total and android fat mass, indicating that GDF8 and activin A are dominant physiological regulators of human muscle and fat mass.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A single injection of two specific antibodies in healthy postmenopausal women aged 45–70 increases thigh muscle volume by about 6% and reduces total and abdominal fat mass over 8 weeks, demonstrating that GDF8 and activin A are key regulators of human muscle and fat mass.
See the scientific wording
In healthy postmenopausal women aged 45–70, a single dose of combined monoclonal antibodies blocking GDF8 (6 mg/kg) and activin A (10 mg/kg) increases thigh muscle volume by approximately 6% over 8 weeks, with corresponding reductions in total and android fat mass, suggesting these ligands are dominant physiological regulators of human muscle and fat mass.
Two proteins that normally stop muscle growth and encourage fat storage are blocked by special antibodies. This allows muscle cells to make more protein and grow larger, while fat cells stop storing as much fat, leading to more muscle and less fat in the body.
What the research says
1 studyScientists gave older women two special injections that block two proteins (GDF8 and activin A) that normally limit muscle growth and promote fat storage. After two months, the women’s leg muscles got bigger and their belly fat went down, exactly as the claim said.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.